VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > OH OH TOO MUCH LUBE

<< Previous

Bullboard Posts

Next >>

Comment by bluemoons20on Dec 13, 2021 4:36pm

94 Views

Post# 34226598

RE:RE:OH OH TOO MUCH LUBE

Good for you. At this point I will not buy any more . I will wait with what I have.

I thought we were ready to go with the Ventripoint product.?? The Blog says the 3D version not rady until end of next year??

Where is this BLOG from does not show any source /name attached??

The reality is that had 2022 been mentioned earlier , I would have been out at 60.

Good luck to you with 'filling your boots' with this stock - at this point you are doing better than the people who bought the financing but overall a bit disappointing if we are now going to wait another year??

GLTA

<< Previous

Bullboard Posts

Next >>

Cloud DX among leading remote patient monitoring suppliers in Canada